Doses of rituximab for retreatment in rheumatoid arthritis: influence on maintenance and risk of serious infection

Abstract

Use of reduced doses of RTX for retreatment did not alter the maintenance of RTX at 5 years in RA patients, but allowed a 39% total dose reduction and a lower rate of serious infections.